Dangerous and cancer-causing properties of products and chemicals in the oil refining and petrochemical industries. Part XXX - Causal relationship between chronic myelogenous leukemia and benzene-containing solvents

被引:15
作者
Mehlman, Myron A.
机构
[1] Mt Sinai Med Ctr, Dept Med, New York, NY USA
[2] Univ Texas, Med Branch, Galveston, TX 77550 USA
来源
LIVING IN A CHEMICAL WORLD: FRAMING THE FUTURE IN LIGHT OF THE PAST | 2006年 / 1076卷
关键词
benzene; leukemia; CML; chronic myelogenous leukemia; solvents; cancer;
D O I
10.1196/annals.1371.065
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Benzene and benzene-containing products and solvents have long been associated with bone marrow toxicity. Both animal studies and human epidemiological studies have shown statistically significant increases of leukemia and other lymphohematopoietic cancers in workers exposed to benzene. The most common leukemia that has been associated with benzene exposure, also called benzene poisoning, is acute myelocytic leukemia (AML). A review of the epidemiological literature on workers exposed to benzene or benzene-containing solvents and products shows, without question, that this exposure is significantly related to other types of leukemia and lymphoma. In this article, we review the literature on the relationship between benzene exposure and chronic myelogenous leukemia (CML) and find that benzene and benzene-containing products are significantly related to morbidity and mortality from CML.
引用
收藏
页码:110 / 119
页数:10
相关论文
共 69 条
[1]   Occupational history and exposure and the risk of adult leukemia in Shanghai [J].
Adegoke, OJ ;
Blair, A ;
Shu, XO ;
Sanderson, M ;
Jin, F ;
Dosemeci, M ;
Addy, CL ;
Zheng, W .
ANNALS OF EPIDEMIOLOGY, 2003, 13 (07) :485-494
[2]   HEMATOTOXICITY AND CARCINOGENICITY OF BENZENE [J].
AKSOY, M .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1989, 82 :193-197
[3]  
Askey J M, 1928, Cal West Med, V29, P262
[4]  
*ATSDR, 1998, TOX PROF BENZ
[5]  
BOENHEIM AF, 1973, PETROLEUM HYDROCARBO
[6]  
BOND GG, 1986, BRIT J IND MED, V43, P685
[7]  
BOUSSER J, 1951, Arch Mal Prof, V12, P399
[8]  
BRADFORDHILL A, 1965, P ROY SOC MED, V58, P295
[9]  
BROWNING E, 1965, TOXICITY METABOLISM, P3
[10]  
CHRISTIE D, 1991, BRIT J IND MED, V48, P511